Replies to post #45615 on OncoSec Medical Inc (ONCSQ)

[Backstabbed]

MMs don’t understand all the related data.

All they know how to do is kill retail to make money. That’s what they did today.

This will move back up slowly but surely

[dr_lowenstein]

ah, I see, so this is actually good news?? LOL ok, sure

[dangerM]

Aaaaaaargh (sorry, I had to write this ... a little drop, ok, but the market is reacting as if Pisces had totally failed - it did not, we have a late-breaker at SITC!).

The above said, I absolutely support each and every word of your post!

It's "unresectable melanoma", "refractory to anti-PD-1 monoclonal antibodies" and excluding those that are "suitable for local therapy administered with curative intent"! (all phrases quoted from the clinical trial entry). People that have completely run out of all options, possibly/probably even some CTLA4-non-responders (so I speculated in one of my previous posts).

At the Biotech Values board, Dew wrote "Holding a CC to tout these interim data was probably a bad idea.". Or at least, they should have adjusted the market's expectations (the case numbers are too small to make any comparison, but hey, we have at least as many responders as DVAX has in such a population ... I also wrote that there https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144710033).

[akhsv777]

Hschlaugh - thank you!!! Absolutely insane market reaction on a extremely challenging trial. I am sure it will be adjusted accordingly in coming days.